ASTRO FINANCE PREDICTION PRICE & FUTURE When will crash? MRNA WEEKLY VIEW MRNA DAILY VIEW MRNA In 2010, ModeRNA Therapeutics was formed to commercialize the research of stem cell biologist Derrick Rossi. Rossi had discovered the works of Hungarian biochemist Katalin Karikó on RNA-mediated immune activation, which resulted in the co-discovery with American immunologist Drew Weissman of the nucleoside modifications that suppress the immunogenicity of RNA. This technology would later be licensed and used by Moderna and BioNTech to develop COVID-19 vaccines In March 2013, Moderna and AstraZeneca signed a five-year exclusive option agreement to discover, develop, and commercialize mRNA for treatments in the therapeutic areas of cardiovascular, metabolic, and renal diseases, and selected targets for cancer. The agreement included a $240 million upfront payment to Moderna, a payment which was "one of the largest ever initial payments in a pharmaceutical industry licensing deal that does not involve a drug already being tested in clinical trials",[20] As of May 2020, only one candidate has passed Phase I trials, a treatment for myocardial ischemia, MRNA In 2018, the company rebranded as "Moderna Inc." and further increased its portfolio of vaccine development. In July 2018, the company opened a 200,000 square foot facility in Norwood, Massachusetts for manufacturing, preclinical and clinical work. In December 2018, Moderna became a public company via the largest biotech initial public offering in history, raising $621 million. In March 2020, in a White House meeting between the Trump administration and pharmaceutical executives, Bancel told the president Moderna could have a COVID-19 vaccine ready in a few months. The next day, the FDA approved clinical trials for the Moderna vaccine candidate, with Moderna later receiving investment of $483 million from Operation Warp Speed. Moderna board member, Moncef Slaoui, was appointed head scientist for the Operation Warp Speed project MRNA July 2021, phase 1 clinical study of influenza vaccine begins, code name mRNA-1010 MRNA WEEKLY VIEW MRNA FUTURE PRICE TRY TO ANSWER: - WHY mRNA grew 3200% since 2019? - HOW mRNA price predicts world health situation? - What may happen in 2022? MRNA DAILY CHART: FUTURE PRICE ASTRO-FINANCE METHOD GENERAL LINE MRNA DAILY CHART: FUTURE PRICE ASTRO-FINANCE METHOD GENERAL LINE MRNA GENERAL LINE WEEKLY CHART: FUTURE PRICE ASTRO-FINANCE METHOD ON DEMAND PREDICTIONS ON DEMAND PREDICTIONS 6 MONTHS AHEAD.